Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lingzhi in early Parkinson's disease
NCT00224263Phase 2Completed
- Sponsor
- Xuanwu Hospital
- Start
- Sep 2005
- Modality
- HM (Herbal Medicine), Nutraceutical
- Countries
- 1
01
Overview
A Phase 2 trial of ganoderma lucidum in Parkinson's disease (PD), sponsored by Xuanwu Hospital. Started Sep 2005; status: completed.
02
Drugs
ganoderma lucidum
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00224263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224263.